Aurobindo Pharma USA Invests $31.7 million to Establish National Headquarters in Durham, North Carolina


The New Jersey-based Aurobindo Pharma USA maker of generic pharmaceuticals plans to invest over $31.7 million in a new state-of-the-art national headquarters for specialty pharmaceutical R&D.


Aurobindo Pharma USA will establish a new R&D and manufacturing center in Durham. This investment will bring 275 new R&D and pharma-manufacturing jobs to Durham, North Carolina.

The company currently employs 14 scientists/workers in Raleigh. Among the new employees will be researchers, analytical chemists, production operators, quality control specialists and others.

We are very excited about our plans for expansion of our specialty pharma R&D and manufacturing in North Carolina, and are thankful to EDPNC, Durham City, Durham County and the State of North Carolina for supporting our decision. North Carolina has one of the best talent pools in the specialty pharma R&D and manufacturing sectors, and we look forward to establishing a large and successful footprint here said Dr. Ninad Deshpanday, President, R&D, Aurobindo Pharma USA, Inc.


Name Aurobindo Pharma USA, Inc.
Location Durham, North Carolina
Type New Headquarters
Estimated Cost $31.7 Million